SOLVSolventum
Is the price fair?
Cheap vs its sector. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Sector median 22.6× across 130 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What SOLV's price assumes
Solventum trades at 10.7× earnings against 39.6× for the median Medical Instruments & Supplies name, cheaper than its own group.
Trailing P/E · Medical Instruments & Supplies median 39.6 · cheaper than the typical name in its group
- Price / sales
- 1.57
Price / sales · today's price, trailing year to Jun 30, 2026
- Price / book
- 2.72
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 2.13
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 2.72
- EV / EBITtoday's price, trailing year to Jun 30, 2026
- 8.54
- EV / salestoday's price, trailing year to Jun 30, 2026
- 2.13
- Healthcare median P/E509 names
- 26.2
- Medical Instruments & Supplies median P/E33 names
- 39.6
- Market capitalisation
- $13.1B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
The closest names by size in the same industry